Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Molecular Diagnostics In Cancer Testing industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Counsyl
Pathway Genomics
Genomictree
Agendia
Clarient, Inc (GE Healthcare)
LabCorp
Genmark Diagnostics
NSTG
Ambry Genetics
Genomic Health
Neogenomics
Exiqon
BioMerieux
Invitae
Cancer Genetics
Nuvera Biosciences
Biodesix
Abbott Molecular Diagnostics
BioTheranostics (AviaraDx)
Genoptix (Novartis)
Orion Genomics
HTG Molecular Diagnostics
Myriad Genetics
Nanostring
Flatiron Health
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Molecular Diagnostics In Cancer Testing Market Overview 2018-2029
-
1.1 China Molecular Diagnostics In Cancer Testing Industry Development Overview
-
1.2 China Molecular Diagnostics In Cancer Testing Industry Development History
-
1.3 China Molecular Diagnostics In Cancer Testing Industry Market Size (2018-2029)
-
1.4 China Molecular Diagnostics In Cancer Testing Market Analysis by Type from Production Side
-
1.4.1 China Molecular Diagnostics In Cancer Testing Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Molecular Diagnostics In Cancer Testing Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Molecular Diagnostics In Cancer Testing Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Molecular Diagnostics In Cancer Testing Market Analysis by Application from Consumption End
-
1.5.1 China Molecular Diagnostics In Cancer Testing Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Molecular Diagnostics In Cancer Testing Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Molecular Diagnostics In Cancer Testing Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Molecular Diagnostics In Cancer Testing Market Analysis by Region
-
1.6.1 North China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
Chapter 2 China Molecular Diagnostics In Cancer Testing Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Molecular Diagnostics In Cancer Testing Market Status and Competition at home and abroad in 2023
-
2.2.2 China Molecular Diagnostics In Cancer Testing Market Status and Competition Analysis in 2023
-
2.2.3 China Molecular Diagnostics In Cancer Testing Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Molecular Diagnostics In Cancer Testing Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Molecular Diagnostics In Cancer Testing Industry Development
Chapter 3 Molecular Diagnostics In Cancer TestingIndustry Chain Analysis
-
3.1 Molecular Diagnostics In Cancer Testing Industry Chain
-
3.2 Molecular Diagnostics In Cancer Testing Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Molecular Diagnostics In Cancer Testing Market
-
3.3 Molecular Diagnostics In Cancer Testing Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Molecular Diagnostics In Cancer Testing Market
Chapter 4 China Molecular Diagnostics In Cancer Testing Market, by Type
-
4.1 China Molecular Diagnostics In Cancer Testing Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Molecular Diagnostics In Cancer Testing Total Production Volume and Growth Rate from Production Side
-
4.5 China Molecular Diagnostics In Cancer Testing Production Volume and Growth Rate, by Type
-
4.5.1 China Molecular Diagnostics In Cancer Testing Production Volume and Growth Rate of Type 1
-
4.5.2 China Molecular Diagnostics In Cancer Testing Production Volume and Growth Rate of Type 2
-
4.5.3 China Molecular Diagnostics In Cancer Testing Production Volume and Growth Rate of Type 3
Chapter 5 China Molecular Diagnostics In Cancer Testing Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Molecular Diagnostics In Cancer Testing Total Market Size and Growth Rate from Consumption End
-
5.5 China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate, by Application
-
5.5.1 China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Application 1
-
5.5.2 China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Application 2
-
5.5.3 China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Application 3
Chapter 6 China Molecular Diagnostics In Cancer Testing Market, by Region
-
6.1 China Molecular Diagnostics In Cancer Testing Production Volume and Production Value, by Region
-
6.2 China Molecular Diagnostics In Cancer Testing Sales Volume and Sales Value, by Region
Chapter 7 North China Molecular Diagnostics In Cancer Testing Market Analysis
-
7.1 North China Molecular Diagnostics In Cancer Testing Market, by Type
-
7.2 North China Molecular Diagnostics In Cancer Testing Market, by Application
Chapter 8 Central China Molecular Diagnostics In Cancer Testing Market Analysis
-
8.1 Central China Molecular Diagnostics In Cancer Testing Market, by Type
-
8.2 Central China Molecular Diagnostics In Cancer Testing Market, by Application
Chapter 9 South China Molecular Diagnostics In Cancer Testing Market Analysis
-
9.1 South China Molecular Diagnostics In Cancer Testing Market, by Type
-
9.2 South China Molecular Diagnostics In Cancer Testing Market, by Application
Chapter 10 East China Molecular Diagnostics In Cancer Testing Market Analysis
-
10.1 East China Molecular Diagnostics In Cancer Testing Market, by Type
-
10.2 East China Molecular Diagnostics In Cancer Testing Market, by Application
Chapter 11 Northeast China Molecular Diagnostics In Cancer Testing Market Analysis
-
11.1 Northeast China Molecular Diagnostics In Cancer Testing Market, by Type
-
11.2 Northeast China Molecular Diagnostics In Cancer Testing Market, by Application
Chapter 12 Southwest China Molecular Diagnostics In Cancer Testing Market Analysis
-
12.1 Southwest China Molecular Diagnostics In Cancer Testing Market, by Type
-
12.2 Southwest China Molecular Diagnostics In Cancer Testing Market, by Application
Chapter 13 Northwest China Molecular Diagnostics In Cancer Testing Market Analysis
-
13.1 Northwest China Molecular Diagnostics In Cancer Testing Market, by Type
-
13.2 Northwest China Molecular Diagnostics In Cancer Testing Market, by Application
Chapter 14 Company Profiles
-
14.1 Counsyl
-
14.1.1 Counsyl Company Profile
-
14.1.2 Counsyl Molecular Diagnostics In Cancer Testing Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pathway Genomics
-
14.2.1 Pathway Genomics Company Profile
-
14.2.2 Pathway Genomics Molecular Diagnostics In Cancer Testing Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Genomictree
-
14.3.1 Genomictree Company Profile
-
14.3.2 Genomictree Molecular Diagnostics In Cancer Testing Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Agendia
-
14.4.1 Agendia Company Profile
-
14.4.2 Agendia Molecular Diagnostics In Cancer Testing Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Clarient, Inc (GE Healthcare)
-
14.5.1 Clarient, Inc (GE Healthcare) Company Profile
-
14.5.2 Clarient, Inc (GE Healthcare) Molecular Diagnostics In Cancer Testing Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 LabCorp
-
14.6.1 LabCorp Company Profile
-
14.6.2 LabCorp Molecular Diagnostics In Cancer Testing Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Genmark Diagnostics
-
14.7.1 Genmark Diagnostics Company Profile
-
14.7.2 Genmark Diagnostics Molecular Diagnostics In Cancer Testing Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 NSTG
-
14.8.1 NSTG Company Profile
-
14.8.2 NSTG Molecular Diagnostics In Cancer Testing Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Ambry Genetics
-
14.9.1 Ambry Genetics Company Profile
-
14.9.2 Ambry Genetics Molecular Diagnostics In Cancer Testing Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Genomic Health
-
14.10.1 Genomic Health Company Profile
-
14.10.2 Genomic Health Molecular Diagnostics In Cancer Testing Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Neogenomics
-
14.11.1 Neogenomics Company Profile
-
14.11.2 Neogenomics Molecular Diagnostics In Cancer Testing Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Exiqon
-
14.12.1 Exiqon Company Profile
-
14.12.2 Exiqon Molecular Diagnostics In Cancer Testing Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 BioMerieux
-
14.13.1 BioMerieux Company Profile
-
14.13.2 BioMerieux Molecular Diagnostics In Cancer Testing Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Invitae
-
14.14.1 Invitae Company Profile
-
14.14.2 Invitae Molecular Diagnostics In Cancer Testing Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Cancer Genetics
-
14.15.1 Cancer Genetics Company Profile
-
14.15.2 Cancer Genetics Molecular Diagnostics In Cancer Testing Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Nuvera Biosciences
-
14.16.1 Nuvera Biosciences Company Profile
-
14.16.2 Nuvera Biosciences Molecular Diagnostics In Cancer Testing Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Biodesix
-
14.17.1 Biodesix Company Profile
-
14.17.2 Biodesix Molecular Diagnostics In Cancer Testing Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Abbott Molecular Diagnostics
-
14.18.1 Abbott Molecular Diagnostics Company Profile
-
14.18.2 Abbott Molecular Diagnostics Molecular Diagnostics In Cancer Testing Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 BioTheranostics (AviaraDx)
-
14.19.1 BioTheranostics (AviaraDx) Company Profile
-
14.19.2 BioTheranostics (AviaraDx) Molecular Diagnostics In Cancer Testing Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Genoptix (Novartis)
-
14.20.1 Genoptix (Novartis) Company Profile
-
14.20.2 Genoptix (Novartis) Molecular Diagnostics In Cancer Testing Market Performance
-
14.20.3 Product&Service Introduction
-
14.21 Orion Genomics
-
14.21.1 Orion Genomics Company Profile
-
14.21.2 Orion Genomics Molecular Diagnostics In Cancer Testing Market Performance
-
14.21.3 Product&Service Introduction
-
14.22 HTG Molecular Diagnostics
-
14.22.1 HTG Molecular Diagnostics Company Profile
-
14.22.2 HTG Molecular Diagnostics Molecular Diagnostics In Cancer Testing Market Performance
-
14.22.3 Product&Service Introduction
-
14.23 Myriad Genetics
-
14.23.1 Myriad Genetics Company Profile
-
14.23.2 Myriad Genetics Molecular Diagnostics In Cancer Testing Market Performance
-
14.23.3 Product&Service Introduction
-
14.24 Nanostring
-
14.24.1 Nanostring Company Profile
-
14.24.2 Nanostring Molecular Diagnostics In Cancer Testing Market Performance
-
14.24.3 Product&Service Introduction
-
14.25 Flatiron Health
-
14.25.1 Flatiron Health Company Profile
-
14.25.2 Flatiron Health Molecular Diagnostics In Cancer Testing Market Performance
-
14.25.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Molecular Diagnostics In Cancer Testing Industry Research Conclusions
-
15.2 Molecular Diagnostics In Cancer Testing Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Molecular Diagnostics In Cancer Testing Industry Market Size (2018-2029)
-
Figure China Molecular Diagnostics In Cancer Testing Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Molecular Diagnostics In Cancer Testing Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Molecular Diagnostics In Cancer Testing Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Molecular Diagnostics In Cancer Testing Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Molecular Diagnostics In Cancer Testing Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Molecular Diagnostics In Cancer Testing Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
Figure Central China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
Figure South China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
Figure East China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate from 2018-2029
-
Figure Molecular Diagnostics In Cancer Testing Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Molecular Diagnostics In Cancer Testing Market Share by Type in 2018
-
Figure China Molecular Diagnostics In Cancer Testing Market Share by Type in 2023
-
Figure China Molecular Diagnostics In Cancer Testing Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Market Share by Application in 2018
-
Figure China Molecular Diagnostics In Cancer Testing Market Share by Application in 2023
-
Figure China Molecular Diagnostics In Cancer Testing Total Market Size and Growth Rate from Consumption End
-
Figure China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Production Volume by Region (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Production Volume Share by Region (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Production Volume Share by Region (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Production Value by Region (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Production Value Share by Region (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Production Value Share by Region (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Sales Volume by Region (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Sales Volume Share by Region (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Sales Volume Share by Region (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Sales Value by Region (2018-2023)
-
Table China Molecular Diagnostics In Cancer Testing Sales Value Share by Region (2018-2023)
-
Figure China Molecular Diagnostics In Cancer Testing Sales Value Share by Region (2018-2023)
-
Table North China Molecular Diagnostics In Cancer Testing Production Volume by Type (2018-2023)
-
Table North China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Figure North China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Table North China Molecular Diagnostics In Cancer Testing Sales Volume by Application (2018-2023)
-
Table North China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Figure North China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Table Central China Molecular Diagnostics In Cancer Testing Production Volume by Type (2018-2023)
-
Table Central China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Figure Central China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Table Central China Molecular Diagnostics In Cancer Testing Sales Volume by Application (2018-2023)
-
Table Central China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Figure Central China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Table South China Molecular Diagnostics In Cancer Testing Production Volume by Type (2018-2023)
-
Table South China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Figure South China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Table South China Molecular Diagnostics In Cancer Testing Sales Volume by Application (2018-2023)
-
Table South China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Figure South China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Table East China Molecular Diagnostics In Cancer Testing Production Volume by Type (2018-2023)
-
Table East China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Figure East China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Table East China Molecular Diagnostics In Cancer Testing Sales Volume by Application (2018-2023)
-
Table East China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Figure East China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Table Northeast China Molecular Diagnostics In Cancer Testing Production Volume by Type (2018-2023)
-
Table Northeast China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Figure Northeast China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Table Northeast China Molecular Diagnostics In Cancer Testing Sales Volume by Application (2018-2023)
-
Table Northeast China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Table Southwest China Molecular Diagnostics In Cancer Testing Production Volume by Type (2018-2023)
-
Table Southwest China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Figure Southwest China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Table Southwest China Molecular Diagnostics In Cancer Testing Sales Volume by Application (2018-2023)
-
Table Southwest China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Table Northwest China Molecular Diagnostics In Cancer Testing Production Volume by Type (2018-2023)
-
Table Northwest China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Figure Northwest China Molecular Diagnostics In Cancer Testing Production Volume Share by Type (2018-2023)
-
Table Northwest China Molecular Diagnostics In Cancer Testing Sales Volume by Application (2018-2023)
-
Table Northwest China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Molecular Diagnostics In Cancer Testing Sales Volume Share by Application (2018-2023)
-
Table Counsyl Company Profile
-
Table Counsyl Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Pathway Genomics Company Profile
-
Table Pathway Genomics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Genomictree Company Profile
-
Table Genomictree Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Agendia Company Profile
-
Table Agendia Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Clarient, Inc (GE Healthcare) Company Profile
-
Table Clarient, Inc (GE Healthcare) Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table LabCorp Company Profile
-
Table LabCorp Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Genmark Diagnostics Company Profile
-
Table Genmark Diagnostics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table NSTG Company Profile
-
Table NSTG Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Ambry Genetics Company Profile
-
Table Ambry Genetics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Genomic Health Company Profile
-
Table Genomic Health Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Neogenomics Company Profile
-
Table Neogenomics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Exiqon Company Profile
-
Table Exiqon Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table BioMerieux Company Profile
-
Table BioMerieux Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Invitae Company Profile
-
Table Invitae Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Cancer Genetics Company Profile
-
Table Cancer Genetics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Nuvera Biosciences Company Profile
-
Table Nuvera Biosciences Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Biodesix Company Profile
-
Table Biodesix Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Abbott Molecular Diagnostics Company Profile
-
Table Abbott Molecular Diagnostics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table BioTheranostics (AviaraDx) Company Profile
-
Table BioTheranostics (AviaraDx) Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Genoptix (Novartis) Company Profile
-
Table Genoptix (Novartis) Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Orion Genomics Company Profile
-
Table Orion Genomics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table HTG Molecular Diagnostics Company Profile
-
Table HTG Molecular Diagnostics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Myriad Genetics Company Profile
-
Table Myriad Genetics Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Nanostring Company Profile
-
Table Nanostring Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
Table Flatiron Health Company Profile
-
Table Flatiron Health Molecular Diagnostics In Cancer Testing Revenue, Price and Gross (2018-2023)
-
